Melan-A Antibody MA5-14017 from Thermo Fisher Scientific

81 Wyman Street

Waltham, MA 02451

United States

Phone: 800-678-5599
Fax: 800-331-2286

(2) Vaccination with antigen-transfected, NKT cell ligand-loaded, human cells elicits robust in situ immune responses by dendritic cellsCancer researchJanuary 1, 2013Shimizu K, Mizuno T, Shinga J, Asakura M, Kakimi K, Ishii Y, Masuda K, Maeda T, Sugahara H, Sato Y, et al.

(4) Intraglomerular crescentic metastases of malignant melanomaHuman pathologyDecember 1, 2011Ozluk Y, Kilicaslan I, Kazancioglu R, Demirkesen C, Derin D, Mandel NM.

(5) Expression of the embryological morphogen Nodal in stage III/IV melanomaMelanoma researchDecember 1, 2011Hooijkaas AI, Gadiot J, van Boven H, Blank C.

(6) Cellular blue nevus of the uterus: a case report and review of the literatureInternational journal of gynecological pathology : official journal of the International Society of Gynecological PathologistsNovember 1, 2010Eskue K, Prieto VG, Malpica A.

(7) Regulation of human skin pigmentation in situ by repetitive UV exposure: molecular characterization of responses to UVA and/or UVBThe Journal of investigative dermatologyJune 1, 2010Choi W, Miyamura Y, Wolber R, Smuda C, Reinhold W, Liu H, Kolbe L, Hearing VJ.

(8) Glycoprotein nonmetastatic melanoma protein b, a melanocytic cell marker, is a melanosome-specific and proteolytically released proteinFASEB journal : official publication of the Federation of American Societies for Experimental BiologyMay 1, 2010Hoashi T, Sato S, Yamaguchi Y, Passeron T, Tamaki K, Hearing VJ.

(9) Vaccine-specific local T cell reactivity in immunotherapy-associated vitiligo in melanoma patientsCancer immunology, immunotherapy : CIIJanuary 1, 2009Jacobs JF, Aarntzen EH, Sibelt LA, Blokx WA, Boullart AC, Gerritsen MJ, Hoogerbrugge PM, Figdor CG, Adema GJ, Punt CJ, et al.

(10) Cyclobutane pyrimidine dimer formation and p53 production in human skin after repeated UV irradiationExperimental dermatologyNovember 1, 2008Yamaguchi Y, Coelho SG, Zmudzka BZ, Takahashi K, Beer JZ, Hearing VJ, Miller SA.

(11) Dendritic cell vaccine with mRNA targeted to the proteasome by polyubiquitinationBiochemical and biophysical research communicationsJune 27, 2008Hosoi A, Takeda Y, Sakuta K, Ueha S, Kurachi M, Kimura K, Maekawa R, Kakimi K.

(13) Glomus tumor and glomangioma of the nerve. Report of two casesJournal of neurosurgeryFebruary 1, 2008Scheithauer BW, Rodriguez FJ, Spinner RJ, Dyck PJ, Salem A, Edelman FL, Amrami KK, Fu YS.

(15) Immunogenicity, including vitiligo, and feasibility of vaccination with autologous GM-CSF-transduced tumor cells in metastatic melanoma patientsJournal of clinical oncology : official journal of the American Society of Clinical OncologyDecember 10, 2005Luiten RM, Kueter EW, Mooi W, Gallee MP, Rankin EM, Gerritsen WR, Clift SM, Nooijen WJ, Weder P, van de Kasteele WF, et al.

(16) Mechanisms of skin tanning in different racial/ethnic groups in response to ultraviolet radiationThe Journal of investigative dermatologyJune 1, 2005Tadokoro T, Yamaguchi Y, Batzer J, Coelho SG, Zmudzka BZ, Miller SA, Wolber R, Beer JZ, Hearing VJ.

(17) MART-1 is required for the function of the melanosomal matrix protein PMEL17/GP100 and the maturation of melanosomesThe Journal of biological chemistryApril 8, 2005Hoashi T, Watabe H, Muller J, Yamaguchi Y, Vieira WD, Hearing VJ.

(18) On the role of melanoma-specific CD8+ T-cell immunity in disease progression of advanced-stage melanoma patientsClinical cancer research : an official journal of the American Association for Cancer ResearchJuly 15, 2004van Oijen M, Bins A, Elias S, Sein J, Weder P, de Gast G, Mallo H, Gallee M, Van Tinteren H, Schumacher T, et al.

IHC